Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

• DOI: 10.6004/jnccn.2018.0083
• Publication Date: 2018-11-16T06:15:45Z
• Authors: Therese B. Bevers; Mark Helvie; Ermelinda Bonaccio; Kristine E. Calhoun; Mary B. Daly; William B. Farrar; Judy E. Garber; Richard Gray; Caprice C. Greenberg; Rachel Greenup; Nora M. Hansen; Randall E. Harris; Alexandra S. Heerdt; Teresa Helsten; Linda Hodgkiss; Tamarya L. Hoyt; John G. Huff; Lisa Jacobs; Constance Dobbins...; Barbara Monsees; Bethany L. Niell; Catherine C. Parker; Mark Pearlman; Liane Philpotts; Laura B. Shepardson; Mary Lou Smith; Matthew Stein; Lusine Tumyan; Cheryl Williams; Mary Anne Bergman; Rashmi Kumar
• Keywords: Adult; Biopsy; Incidence; Clinical Decision-Making; Age Factors; Breast Neoplasms; Middle Aged; Medical Oncology; United States; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Humans; Mass Screening; Female; Breast; Early Detection of Cancer; Societies, Medical; Mammography

The NCCN Guidelines for Breast Cancer Screening and Diagnosis have been developed to facilitate clinical decision making. This manuscript discusses the diagnostic evaluation of individuals with suspected breast cancer due to either abnormal imaging and/or physical findings. For breast cancer screening recommendations, please see the full guidelines on NCCN.org.